Clinicopathologic Features and Response to Pembrolizumab Neoadjuvant Therapy in Triple Negative Breast Cancer (TNBC): A Single Institution Experience

被引：0
|
作者：
Carames, Gian [1 ]
Ning, Bohan [2 ]
Khoury, Katia [1 ]
Wei, Shi [3 ]
Xu, Jia [1 ]
Guo, Hua [2 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] UAB Hosp, Birmingham, AL USA
[3] Univ Kansas, Sch Med, Kansas City, KS USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [21] Spatial mapping of the immune microenvironment in primary triple-negative breast cancer (TNBC) and association with neoadjuvant therapy response
    Telli, M. L.
    Vinayak, S.
    Khododoust, M. S.
    Gruber, J. J.
    Ford, J. M.
    Sanchez, P.
    Banayan, N.
    Azimi, S.
    Tumeh, P. C.
    Newman, A. M.
    Alizadeh, A. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [22] NEOIRX: A PHASE II TRIAL OF LOCOREGIONAL CYTOKINE THERAPY TO PROMOTE IMMUNOLOGIC PRIMING AND CLINICAL RESPONSE TO NEOADJUVANT PEMBROLIZUMAB PLUS CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Sanchez, Katherine
    Conlin, Alison
    Peddi, Parvin
    Stanton, Sasha
    Ruzich, Janet
    Perlewitz, Kelly
    Wu, Yaping
    Moxon, Nicole
    Mellinger, Staci
    Sun, Zhaoyu
    Redmond, William
    Page, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A430 - A430
  • [23] Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
    Abeer H. Abdelhafez
    Benjamin C. Musall
    Beatriz E. Adrada
    KennethR. Hess
    Jong Bum Son
    Ken-Pin Hwang
    Rosalind P. Candelaria
    Lumarie Santiago
    Gary J. Whitman
    Huong T. Le-Petross
    Tanya W. Moseley
    Elsa Arribas
    Deanna L. Lane
    Marion E. Scoggins
    Jessica W. T. Leung
    Hagar S. Mahmoud
    Jason B. White
    Elizabeth E. Ravenberg
    Jennifer K. Litton
    Vicente Valero
    Peng Wei
    Alastair M. Thompson
    Stacy L. Moulder
    Mark D. Pagel
    Jingfei Ma
    Wei T. Yang
    Gaiane M. Rauch
    Breast Cancer Research and Treatment, 2021, 185 : 1 - 12
  • [24] Clinicopathologic Features, Genomic Profiles and Neoadjuvant Chemotherapy Response in Triple Negative Breast Cancer According to Androgen Receptor Expression
    Vougiouklakis, Theodore
    Polidorio, Natalia
    Downs-Canner, Stephanie
    Schwartz, Christopher
    Brogi, Edi
    Montagna, Giacomo
    Wen, Hannah
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [25] Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
    Abdelhafez, Abeer H.
    Musall, Benjamin C.
    Adrada, Beatriz E.
    Hess, KennethR.
    Son, Jong Bum
    Hwang, Ken-Pin
    Candelaria, Rosalind P.
    Santiago, Lumarie
    Whitman, Gary J.
    Le-Petross, Huong T.
    Moseley, Tanya W.
    Arribas, Elsa
    Lane, Deanna L.
    Scoggins, Marion E.
    Leung, Jessica W. T.
    Mahmoud, Hagar S.
    White, Jason B.
    Ravenberg, Elizabeth E.
    Litton, Jennifer K.
    Valero, Vicente
    Wei, Peng
    Thompson, Alastair M.
    Moulder, Stacy L.
    Pagel, Mark D.
    Ma, Jingfei
    Yang, Wei T.
    Rauch, Gaiane M.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 1 - 12
  • [26] Outcomes of neoadjuvant (NA) and adjuvant (A) chemotherapy in geriatric patients with stage I-III triple-negative breast cancer (TNBC): A single institution experience.
    Sam, Christine
    Sehovic, Marina
    Extermann, Martine
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Clinicopathologic features and survival of Filipino women with triple-negative breast cancer: A single-center experience
    Ando, Mark M.
    Uson, Arnold John B.
    ANNALS OF ONCOLOGY, 2021, 32 : S307 - S307
  • [28] Effect of pembrolizumab as neoadjuvant therapy in early triple-negative breast cancer: a systematic review
    Sunaryo, R. V.
    Meta, C. P.
    Amelia, Z.
    Harahap, S.
    Briegetta, M.
    Jhoputri, C. F.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1391 - S1392
  • [29] Pembrolizumab in the neoadjuvant Treatment of early triple-negative Breast Cancer
    Dierks, Friederike
    Pietsch, Elisabeth
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 841 - 843
  • [30] Prognostic factors and outcomes in triple negative breast cancer - A single institution experience
    Apuri, S.
    Sun, W.
    Bardhan, P.
    Minton, S.
    Soliman, H.
    Han, H. S.
    Lee, J-H
    Fulp, W.
    Ismail-Khan, R.
    CANCER RESEARCH, 2013, 73
12345